Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Technetium-99m Stories

2013-03-05 08:28:12

NEW YORK, March 5, 2013 /PRNewswire/ -- New Market Research Report Added in MarketResearchReports.Biz Reports Database Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 [http://www.marketresearchreports.biz/analysis/139214 ] Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has...

2013-02-24 23:02:40

According to a new market report published by Transparency Market Research, "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global market for radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. Browse the full report at http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html Albany, New York (PRWEB)...

2013-02-20 08:27:31

ALBANY, New York, February 20, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com), "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global market for radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. North America led the...

2012-09-06 02:30:48

BALTIMORE, Sept. 6, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), - is pleased to announce that Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, and Positron Corporation (hereinafter "Positron"), have executed a Letter of Intent pertaining to: (a) Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator; (b) JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to end-users...

2012-06-11 18:26:49

A University of Alberta team has made an important breakthrough in the race to find a viable replacement for supply of technetium-99m, an important isotope produced by Canada's Chalk River reactor. Their research has proven that this important medical isotope, used in nuclear medicine imaging for about 250,000 Alberta patients each year, can be created in a device known as a cyclotron–and is as safe to use and provides as reliable an image as reactor-based isotopes. Their results are...

2011-06-03 08:00:00

ATLANTA, June 3, 2011 /PRNewswire/ -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) today announced it has signed an exclusive option agreement with Battelle, which operates Pacific Northwest National Laboratory for the U.S. Department of Energy, to license technology from PNNL for use with Perma-Fix's proprietary process to safely and cost-effectively produce Molybdenum-99 (Mo-99), which is used to make Technetium 99m (Tc-99m).Tc-99m is the most widely used medical isotope...

2010-10-21 00:00:40

MiPod Nuclear Inc. agrees to territorial licensing agreement for Australia and New Zealand with Vector Trading Corporation Pty/Ltd. The license gives Vector Trading Corporation the exclusive rights to manufacture and distribute Mo-99 produced with MiPod's patent pending medical isotope production on demand technology. Las Vegas, NV (PRWEB) October 20, 2010 MiPod Nuclear Inc. agrees to first territorial license agreement under its plan for worldwide commercial deployment of its medical...

2010-09-23 05:00:00

MDS Nordion secures exclusive Mo-99 supply through framework agreement OTTAWA, Sept. 23/> /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of products and services to the global health science market, today announced it has entered into a framework agreement with The Open Joint Stock Company "Isotope" (Isotope), the authorized subsidiary of Rosatom State Corporation, to explore and define areas of collaboration in the field of supply, marketing and sale of isotopes produced in...

2010-09-09 01:00:20

Twenty million medical scans and treatments are done each year that require radioactive isotopes, and scientists today described a global shortage of these life-saving materials that could jeopardize patient care and drive-up health care costs. They spoke at a symposium at one of the opening sessions of the 240th National Meeting of the American Chemical Society. Medical isotopes are minute amounts of radioactive substances used to diagnose and treat a variety of diseases. Isotopes injected...

2010-08-24 08:01:18

Scientists fear that a global shortage of radioactive isotopes, required for the 20 million medical scans and treatments done each year, could jeopardize patient care and drive up health care costs. Medical isotopes are used to diagnose and treat a variety of diseases. Isotopes injected into the body can enable doctors to determine whether the heart has adequate blood flow or whether cancer has spread to a patient's bones. Isotopes help diagnose gallbladder, kidney, and brain disorders. When...